
Company News
-3.17% percent quarterly performance for Acumen Pharmaceuticals Inc (ABOS) is not indicative of the underlying story
On Tuesday, Acumen Pharmaceuticals Inc (NASDAQ: ABOS) was 7.02% up from the session before settling in for the closing price of $1.14. A 52-week range